It has been reported that inhibition of MAPK (Erk) activity by PD0325901, a MEK inhibitor, promotes OPC differentiation and myelin regeneration in two different animal models of the demyelinating disease (Suo et al., 2019). The gene discussed is MAP2K7; the disease is demyelinating disease.